Daniel Marechal
Direktor/Vorstandsmitglied bei Targetome NV
Profil
Daniel Marechal is currently a Director at Targetome NV since 2016.
Prior to this, he worked as a General Director at Artialis SA and as a Manager-Business Development at Kaneka Eurogentec SA. He obtained a doctorate degree from the University of Liege in 1991.
Aktive Positionen von Daniel Marechal
| Unternehmen | Position | Beginn |
|---|---|---|
Targetome NV
 Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Direktor/Vorstandsmitglied | 23.06.2016 |
Ehemalige bekannte Positionen von Daniel Marechal
| Unternehmen | Position | Ende |
|---|---|---|
Kaneka Eurogentec SA
 Kaneka Eurogentec SA BiotechnologyHealth Technology Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium. | Corporate Officer/Principal | - |
Artialis SA
 Artialis SA Medical/Nursing ServicesHealth Services Artialis SA develops and commercializes immunoassays for the diagnostic and the prognostic disorders. Its products include Urine F3F ELISA, Urine COLL2-2NO2 ELISA, Urine COLL2-1NO2 ELISA and Urine COLL2-1 ELISA. The firm engages in development, analysis and marketing diagnostic kits including in the field of diseases of the musculoskeletal system of humans and animals. The company was founded in 2010 by Yves Henrotin and is headquartered in Liege, Belgium. | Präsident | - |
Ausbildung von Daniel Marechal
| University of Liege | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Artialis SA
Artialis SA Medical/Nursing ServicesHealth Services Artialis SA develops and commercializes immunoassays for the diagnostic and the prognostic disorders. Its products include Urine F3F ELISA, Urine COLL2-2NO2 ELISA, Urine COLL2-1NO2 ELISA and Urine COLL2-1 ELISA. The firm engages in development, analysis and marketing diagnostic kits including in the field of diseases of the musculoskeletal system of humans and animals. The company was founded in 2010 by Yves Henrotin and is headquartered in Liege, Belgium. | Health Services |
Kaneka Eurogentec SA
Kaneka Eurogentec SA BiotechnologyHealth Technology Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium. | Health Technology |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | Health Technology |
